respiratory medication News
-
In a Single Real-World Deployment of over 1,300 Patients, Spire Health’s RPM Service Escalated Patients experiencing Respiratory Exacerbation with 68% Accuracy
Spire Health, the leading provider of remote patient monitoring (RPM) for chronic respiratory disease patients, today announced the results of a real-world study of 1,366 patients at a Virginia-based, multi-provider pulmonary clinic. Among the 188 escalations using Spire’s AI-based system, 68% were pharmacologically treated for acute exacerbation by their pulmonologist. The primary ...
By Spire Health
-
COVID-19 Respiratory Monitoring with MediPines AGM100 in Long-Term Care Facilities
Long-term care facilities are facing extraordinary challenges with the devastating and often undetectable presence of COVID-19. Elderly and at-risk residents in retirement homes and assisted living facilities are more likely to suffer with comorbidities which can impact the severity and mortality of those with COVID-19. To meet this growing challenge in the face of rising pandemic, MediPines, a ...
By MediPines
-
Finalists Announced for the 2020 Georgia Healthcare Innovation Challenge (Media Advisory)
WHAT: September 14th, 2020 - Navicent Health, in partnership with Atlanta Tech Village, Georgia HIMSS and TAG Digital Health, has announced the finalists for the 2020 Georgia Healthcare Innovation Challenge (GHIC). Launched in July of 2020, this challenge aims to foster collaboration between medical and technology providers to improve the delivery of healthcare in Georgia. On July 30th, Navicent ...
-
Yaguo Made the Second Donation
Yaguo Fight against the Epidemic!! Once again Yaguo have made a donation in order to support the frontline of the epidemic, helping with their innovating products that brings out intensive care and rehabilitation. On March 7th, YAGUO sent to Hubei a new set of respiratory devices, the number goes up to 100 devices worth around 2.2 million RMB, including bionic cough simulator (sputum removal ...
-
Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
Stemedica Cell Technologies, Inc. (“Stemedica”), a San Diego-based biotech company specializing in the manufacture of clinical grade stem cells, announced today that it has signed a Licensing Agreement with Pulthera, LLC for the rights to use, distribute and sell its mesenchymal stem cell technologies in the treatment of COVID-19 and additional pulmonary conditions. The agreement was ...
-
Study Finds MediPines’ Breakthrough Non-invasive Gas Exchange Method Highly Precise: Ideal for Covid Response
A recent clinical study published by medical researchers from UC San Diego School of Medicine has established that an expired breath sampling method is comparable to the long-established blood-based method (ABG) of measuring pulmonary gas exchange efficiency. Published in the American Journal of Physiology Lung Cellular and Molecular Physiology, the study, entitled “Measuring the ...
By MediPines
-
MediPines Wins Prestigious Pediatric Medical Device Competition Focused on COVID-19-Related Technologies
MediPines, a respiratory medical device company, was selected a winner in the special COVID-19 edition of the “Make Your Medical Device Pitch for Kids!” competition presented by FDA-sponsored National Capital Consortium for Pediatric Device Innovation. The competition focused on innovations in COVID-19-related pediatric medical devices that will improve children’s health care, ...
By MediPines
-
AG Industries Increases Production of Ventilator Filters More Than Fifteen Times its Pre-COVID Level, Prepares for Further Growth
AG Industries, which manufactures respiratory filters used in Ventilators, Oxygen Concentrators, and CPAP / BiPAP machines, has executed a 1,500% increase in production of its bacterial / viral filters used for the treatment of COVID-19 patients. With the demand for respiratory therapies continuing to surge due to COVID-19, AG Industries is positioned to continue its role as a critical supplier ...
-
‘GREEN’ MEDICAL PROPELLANT RECEIVES FDA APPROVAL TO PROCEED TO CLINICAL TRIALS
Koura (previously known as Mexichem Fluor), a pioneer in the development of next generation propellants, today announced FDA approval to proceed to clinical trials with Zephex® 152a. This new medical propellant has been under development for several years for use in metered-dose inhalers (MDIs) for treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). ...
By Koura
-
Simeox device is now available in Canada!
We are happy to announce that the #simeox device is now commercially available in Canada. Proud to partner with Novus Medical to help respiratory clinicians improve the life of their patients through access to Simeox. The Simeox device is an efficient and comfortable therapy for distal mucus clearance – for patients suffering from chronic lung conditions associated with chest congestion, ...
By PhysioAssist
-
Eakin Healthcare Group acquires Armstrong Medical continuing an ambitious growth strategy
Northern Ireland headquartered Eakin Healthcare Group has announced it is expanding into a new therapeutic area with the acquisition of Coleraine based Armstrong Medical, which specialises in respiratory care products. The deal represents a diversification for the Group which to date has specialised in ostomy and wound care products. The combined resources of the two indigenous NI healthcare ...
-
Covid-19 respiratory monitoring with MediPines AGM100
MD Tech Review, a premier medical innovation magazine, has voted MediPines as a 2020 Top Ten Patient Monitoring Solution Provider. MediPines’ innovative respiratory technology, AGM100®, is making a positive impact in hospitals battling Covid-19. This industry recognition came about as MediPines introduced the AGM100®, an advanced respiratory monitoring system, commercially in the ...
By MediPines
-
Liberate Medical Reports Positive Pilot Trial Results of VentFree Respiratory Muscle Stimulator
Applying non-invasive electrical stimulation to the expiratory abdominal muscles may reduce abdominal muscle atrophy and markedly reduce the number of days adult patients require mechanical ventilation – a potentially important finding for weaning ventilated patients, including seriously ill COVID-19 patients, and improving patient outcomes. Liberate Medical today announced the results of ...
-
Preventing New Cases of Legionnaires’ Disease in Health Care Environments
One in four people that contract Legionnaires’ disease from a health care facility dies according to the Centers for Disease Control and Prevention (CDC). These unsettling figures were posted in June issue of the CDC’s Vitalsigns™ publication. The focus of the document was to raise awareness of the problem of patients contracting Legionnaires’ disease in health care ...
-
Role of oxygen generator in the epidemic period of coronavirus disease
Why is the oxygen generator important? Oxygen is a life-saving therapeutic gas, which is often used to treat patients with severe pneumonia and other respiratory diseases. Oxygen generator is an electric medical equipment. It first inhales air, removes nitrogen, then generates a continuous oxygen source, and delivers concentrated oxygen to patients who need respiratory support in a controlled ...
-
VIDA Expands Global Footprint into Japan with Market Authorization Through Partner Clairvo
VIDA Diagnostics, Inc. (VIDA), the leader in lung and respiratory intelligence, has received market authorization in Japan for its VIDA Insights® software, paving the way for lung care teams to begin using the solution at the point of care. Clairvo Technologies, Inc., a wholly owned subsidiary of Marubeni Corporation, secured the certification from Japan’s Pharmaceuticals and Medical ...
-
NIH investigators find link between DNA damage and immune response
Researchers offer the first evidence that DNA damage can lead to the regulation of inflammatory responses, the body's reaction to injury. The proteins involved in the regulation help protect the body from infection. The study, performed by scientists at the National Institute of Environmental Health Sciences (NIEHS), which is part of the National Institutes of Health, is one of the first studies ...
-
Announcement: Quasar Expands to North America with Commercial Headquarters in Minnetonka, Minnesota
Quasar Medical Devices, LLC is pleased to announce the expansion of our North American Commercial Headquarters in Minnetonka, Minnesota. This expansion strengthens Quasar’s global presence, allowing for a continued focus on supporting North American customers. Located in one of the key medical device clusters, Quasar Medical Devices USA will bring additional commercial support to existing ...
-
N8 Medical Announces its CeraShield™ Coating inhibits COVID-19 Virus Growth on Endotracheal Tubes
N8 Medical, LLC, a privately held biotechnology company, today announced that its CeraShield™ coated endotracheal tubes significantly reduced the growth of COVID-19 virus in recent testing. The testing shows statistically significant reduction in the growth of the COVID-19 virus on the tube surface in 60 minutes. Ordinary uncoated endotracheal tubes either allowed increased virus growth or ...
-
Fluidda and Aptar Pharma Exclusive Collaboration
Fluidda, leader in the field of Functional Respiratory Imaging and developer of the medical device Broncholab®, today announced an exclusive collaboration with Nanopharm, an Aptar Pharma company and a leader in contract research and development services for orally inhaled and nasal drug products (OINDPs). The companies will leverage their respective proprietary technology platforms to help ...
By Fluidda
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you